» Articles » PMID: 18923184

Structural Basis of Protein Kinase C Isoform Function

Overview
Journal Physiol Rev
Specialty Physiology
Date 2008 Oct 17
PMID 18923184
Citations 421
Authors
Affiliations
Soon will be listed here.
Abstract

Protein kinase C (PKC) isoforms comprise a family of lipid-activated enzymes that have been implicated in a wide range of cellular functions. PKCs are modular enzymes comprised of a regulatory domain (that contains the membrane-targeting motifs that respond to lipid cofactors, and in the case of some PKCs calcium) and a relatively conserved catalytic domain that binds ATP and substrates. These enzymes are coexpressed and respond to similar stimulatory agonists in many cell types. However, there is growing evidence that individual PKC isoforms subserve unique (and in some cases opposing) functions in cells, at least in part as a result of isoform-specific subcellular compartmentalization patterns, protein-protein interactions, and posttranslational modifications that influence catalytic function. This review focuses on the structural basis for differences in lipid cofactor responsiveness for individual PKC isoforms, the regulatory phosphorylations that control the normal maturation, activation, signaling function, and downregulation of these enzymes, and the intra-/intermolecular interactions that control PKC isoform activation and subcellular targeting in cells. A detailed understanding of the unique molecular features that underlie isoform-specific posttranslational modification patterns, protein-protein interactions, and subcellular targeting (i.e., that impart functional specificity) should provide the basis for the design of novel PKC isoform-specific activator or inhibitor compounds that can achieve therapeutically useful changes in PKC signaling in cells.

Citing Articles

A Novel Immune-Related Three-Gene Signature and Immune Infiltration Insights in Psoriasis and Chronic Kidney Disease.

Yin T, Zhang T, Ma L Clin Cosmet Investig Dermatol. 2025; 18:267-286.

PMID: 39881853 PMC: 11776511. DOI: 10.2147/CCID.S499202.


Rare variants in cause Van der Woude syndrome and other features of peridermopathy.

Robinson K, Robinson K, Singh S, Walkup R, Fawwal D, Adeyemo W medRxiv. 2025; .

PMID: 39867391 PMC: 11759255. DOI: 10.1101/2025.01.17.25320742.


Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIV.

Gentry Z, McAteer O, Hamad J, Moran J, Kim J, Marsden M Sci Adv. 2025; 11(4):eads1911.

PMID: 39854456 PMC: 11778240. DOI: 10.1126/sciadv.ads1911.


Optogenetic control of Protein Kinase C-epsilon activity reveals its intrinsic signaling properties with spatiotemporal resolution.

Ong Q, Lim C, Liao Y, Tze-Yang Ng J, Lim L, Yi Koh S bioRxiv. 2025; .

PMID: 39829776 PMC: 11741287. DOI: 10.1101/2025.01.06.631444.


The positive implication of natural antioxidants on oxidative stress-mediated diabetes mellitus complications.

Mallik S, Paria B, Firdous S, Ghazzawy H, Alqahtani N, He Y J Genet Eng Biotechnol. 2024; 22(4):100424.

PMID: 39674630 PMC: 11416289. DOI: 10.1016/j.jgeb.2024.100424.


References
1.
DAVIES S, Reddy H, Caivano M, Cohen P . Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000; 351(Pt 1):95-105. PMC: 1221339. DOI: 10.1042/0264-6021:3510095. View

2.
Perander M, Bjorkoy G, Johansen T . Nuclear import and export signals enable rapid nucleocytoplasmic shuttling of the atypical protein kinase C lambda. J Biol Chem. 2000; 276(16):13015-24. DOI: 10.1074/jbc.M010356200. View

3.
Vallentin A, Lo T, Joubert D . A single point mutation in the V3 region affects protein kinase Calpha targeting and accumulation at cell-cell contacts. Mol Cell Biol. 2001; 21(10):3351-63. PMC: 100257. DOI: 10.1128/MCB.21.10.3351-3363.2001. View

4.
Kumar S, Bharti A, Mishra N, Raina D, Kharbanda S, Saxena S . Targeting of the c-Abl tyrosine kinase to mitochondria in the necrotic cell death response to oxidative stress. J Biol Chem. 2001; 276(20):17281-5. DOI: 10.1074/jbc.M101414200. View

5.
Gao T, Toker A, Newton A . The carboxyl terminus of protein kinase c provides a switch to regulate its interaction with the phosphoinositide-dependent kinase, PDK-1. J Biol Chem. 2001; 276(22):19588-96. DOI: 10.1074/jbc.M101357200. View